Company / Gross Margin
Organogenesis Holdings Inc. Gross Margin History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
76.7%
FY2024
5-year range
70.9% / 76.7%
FY2020-FY2024
Trend
+1.5%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Margin has increased for 4 consecutive years, from 64.4% in FY2020 to 76.7% in FY2024.
Based on SEC 10-K filings.
76.7% in FY2024 with a 5-year CAGR of +7.6%.
Improved from 74.2% to 76.7% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- +5.8pp
- 5-Year Change
- +7.6pp
- 10-Year Change
- -
Key checks
Key Insights
- Organogenesis Holdings Inc.'s gross margin has grown for 4 consecutive years.
- In FY2024, gross margin increased 1.5% year-over-year.
- Lowest gross margin in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | 76.7% | +1.5% |
| FY2023 | 75.6% | +1.9% |
| FY2022 | 74.2% | +4.6% |
| FY2021 | 70.9% | +10.0% |
| FY2020 | 64.4% | -6.8% |
| FY2019 | 69.2% | +6.0% |
| FY2018 | 65.3% | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026